HEALIOS LTD

• ⚠

  Material uncertainty over going concern

  At the time of signing these accounts, the directors have considered the cash and funding needs of the group for the next 12 months and are of the opinion the financial statements should be prepared on a going concern basis. In forming this opinion and to ensure the business is a going concern, the Directors recognise the need for additional funding and are in advanced talks to raise additional capital and debt funding in the range of £2m to £3m. This action, plus the letter of support in place from the Autism Impact Fund, will extend the cash runway through for at least the next 12 months from the approval of these accounts.

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  -24.4%

  £21,624,528 → £16,347,575

• Cash

  -50.4%

  £2,857,843 → £1,418,692

• Net assets

  +49%

  -£4,385,100 → -£2,238,211

• Employees

  -43.8%

  470 → 264

• Operating profit

  +74.3%

  -£11,880,985 → -£3,052,631

• Profit before tax

  +74.3%

  -£13,318,841 → -£3,429,227

• Wages

  -40.8%

  £25,549,442 → £15,118,628

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Consolidated group

Auditor

Cooper Parry Group Limited

Audit opinion

Unqualified (clean)

Going concern

Material uncertainty disclosed

“At the time of signing these accounts, the directors have considered the cash and funding needs of the group for the next 12 months and are of the opinion the financial statements should be prepared on a going concern basis. In forming this opinion and to ensure the business is a going concern, the Directors recognise the need for additional funding and are in advanced talks to raise additional capital and debt funding in the range of £2m to £3m. This action, plus the letter of support in place from the Autism Impact Fund, will extend the cash runway through for at least the next 12 months from the approval of these accounts.”

Group structure

1. HEALIOS LTD · parent
   1. Healios USA Inc 100%
   2. Meliora Health Services 0%

Significant events

• “In November 2023 Healios went through a major restructuring of its clinical workforce to better align it with market requirements. The decision was made in 2025 to close Meliora and that action will be completed in June 2025. Subsequent to the balance sheet date, the company made the decision to close its US subsidiaries. The closures were approved by the Board in April 2025, and formal wind-up procedures commenced shortly thereafter.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

6

last 12 months

Capital events

1

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.